Paediatric formulations - Getting to the heart of the problem

International Journal of Pharmaceutics

Volumn 300, Issue 1-2, 2005, Pages 56-66

  Standing, Joseph F ^a,b   Tuleu, Catherine ^b  

^a Great Ormond Street Hospital for Children NHS Trust   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiovascular drugs; Extemporaneous preparations; Licensed liquid; Paediatric medicines; Special products

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; AMIODARONE; AMLODIPINE; ATENOLOL; BOSENTAN; CAPTOPRIL; CARDIOVASCULAR AGENT; CARVEDILOL; CLONIDINE; DIGOXIN; ENALAPRIL; EXCIPIENT; FLECAINIDE; FUROSEMIDE; HYDRALAZINE; NADOLOL; NIFEDIPINE; PRAVASTATIN; PRAZOSIN; PROPRANOLOL; RAMIPRIL; SILDENAFIL; SPIRONOLACTONE; WARFARIN;

ARTICLE; CARDIOVASCULAR DISEASE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; LICENSING; PRESCRIPTION; PRIORITY JOURNAL;

CARDIOVASCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHILD; DRUG AND NARCOTIC CONTROL; HUMANS; SOLUBILITY; SOLUTIONS;

EID: 23444454497     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.05.006     Document Type: Article

References (42)

1. B.J. Anderson, A.D. McKee, and N.H. Holford Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients Clin. Pharmacokinet. 33 1997 313 327
2. Anonymous, 2000. Boots pharmacist and trainee cleared of baby's manslaughter. Pharm. J. 264, 390-392.
3. Anonymous, 2003. Checking paediatric dosing. Pharm. J. 271, 33.
4. K. Arulanantham, and M. Genel Central nervous system toxicity associated with ingestion of propylene glycol J. Pediatr. 93 1978 515 516
5. L. Bigeard The role of medication and sugars in pediatric dental patients Pediatr. Dent. 4493 2000 443 456
6. R.T. Blaszak, J.A. Savage, and E.N. Ellis The use of short-acting nifedipine in pediatric patients with hypertension J. Pediatr. 139 2001 34 37
7. J. Breitkreutz, T. Wessel, and J. Boos Dosage forms for peroral drug administration to children Paediatr. Perinatal Drug Ther. 3 1999 25 33
8. British National Formulary (BNF), number 49, 2005. British Medical Association/Royal Pharmaceutical Society of Great Britain, London, UK.
9. British National Formulary for children (BNF-C), 2005. http://www.bnf.org/bnf/extra/current/noframes/450055.htm, last accessed on the 30th March 2005.
10. M.N. Carrier, O. Garinot, and C. Vitzling Stability and compatibility of tegaserod from crushed tablets mixed in beverages and foods Am. J. Health Syst. Pharm. 61 2004 1135 1142
11. I. Choonara, and S. Conroy Unlicensed and off-label drug use in children: implications for safety Drug Saf. 25 2002 1 5
12. S. Conroy, I. Choonara, P. Impicciatore, A. Mohn, H. Arnell, A. Rane, C. Knoeppel, H. Seyberth, C. Pandolfini, M.P. Raffaelli, F. Rocchi, M. Bonati, G. Jong, M. de Hoog, and J. van den Anker Survey of unlicensed and off label drug use in paediatric wards in European countries European Network for Drug Investigation in Children BMJ 320 2002 79 82
13. D.I. Czyzewski, R.D. Runyan, M.A. Lopez, and N.R. Calles Teaching and maintaining pill swallowing in HIV-infected children AIDS Reader 10 2000 88 95
14. L.L. de Zwart, H.E. Haenen, C.H. Versantvoort, G. Wolterink, J.G. van Engelen, and A.J. Sips Role of biokinetics in risk assessment of drugs and chemicals in children Regul. Toxicol. Pharmacol. 39 2004 282 309
15. J.T. Flynn Nifedipine in the treatment of hypertension in children J. Pediatr. 140 2002 787 788
16. J.T. Flynn, W.E. Smoyer, and T.E. Bunchman Treatment of hypertensive children with amlodipine Am. J. Hypertens. 13 2000 1061 1066
17. Imatinib SPC (Summary of Product Characteristics) (Glivec tablets), 2004. Novartis Pharmaceuticals UK Ltd. Last updated on 14th September 2004; available from URL: http://www.emc.medicines.org.uk.
18. D.A. Johnson, A.C. Roach, A.S. Carlsson, A.A. Karlsson, and D.E. Behr Stability of esomeprazole capsule contents after in vitro suspension in common soft foods and beverages Pharmacotherapy 23 2003 731 734
19. G.L. Kearns, S.M. Abdel-Rahman, S.W. Alander, D.L. Blowey, J.S. Leeder, and R.E. Kauffman Developmental pharmacology-drug disposition, action, and therapy in infants and children N. Engl. J. Med. 349 2003 1157 1167
20. G. Koren, Z. Barzilay, and M. Greenwald Ten fold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics Pediatrics 77 1986 848 849
21. Medicines for Children, 2004. http://pharmacos.eudra.org/F2/Paediatrics/ index.htm, last accessed on the 30th March 2005.
22. T.M. Michele, B. Knorr, E.B. Vadas, and T.F. Reiss Safety of chewable tablets for children J. Asthma 39 2002 391 403
23. M.C. Nahata Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices DICP 25 1991 465 469
24. National Service Framework (Standard 10), 2004. http://www.dh.gov.uk/ assetRoot/04/09/05/63/04090563.pdf, last accessed on the 30th March 2005.
25. D.A. Notterman, M. Nardi, and J.G. Saslow Effect of dose formulation on isoniazid absorption in two young children Pediatrics 77 1986 850 852
26. S. Pawar, and A. Kumar Issues in the formulation of drugs for oral use in children: role of excipients Paediatr. Drug 4 2002 371 379
27. F. Rabiu, P. Forsey, and S. Patel Preservatives can produce harmful effects in paediatric drug preparations Pharm. Pract. 2004 101 108
28. J.M. Rosenberg, J.P. Nathan, and F. Plakogiannis Weight variability of pharmacist-dispensed split tablets J. Am. Pharm. Assoc. (Wash.) 42 2002 200 205
29. Safer and Better medicines for children, 2004. http://www.rcpch.ac.uk/ publications/recent_publications/Safer_Better_Medicines.pdf, last accessed on the 30th March 2005.
30. R. Sasaki, K. Hirota, and A. Masuda Nifedipine-induced transient cerebral ischemia in a child with Cockayne's syndrome Anaesthesia 52 1997 1236
31. E. Schirm, H. Tobi, T.W. de Vries, I. Choonara, and L.T. De Jong-van den Berg Lack of appropriate formulations of medicines for children in the community Acta Paediatr. 92 2003 1486 1489
32. J.F. Standing, and I.C. Wong Chlorproguanil-dapsone for malaria Lancet 364 2004 1752 1753
33. Standing, J.F., Khaki, Z.F., Wong, I.C., in press. Poor formulation information in published pediatric drug trials. Pediatrics.
34. W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K. Chan, J.A. Julian, and L. Mitchell Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients Blood 94 1999 3007 3014
35. K.B. Tallian, M.C. Nahata, M.A. Turman, J.D. Mahan, J.R. Hayes, and M.I. Mentser Efficacy of amlodipine in pediatric patients with hypertension Pediatr. Nephrol. 13 1999 304 310
36. J. Teng, C.K. Song, R.L. Williams, and J.E. Polli Lack of medication dose uniformity in commonly split tablets J. Am. Pharm. Assoc. 42 2002 195 199
37. Tuleu, C., Grangé, J., Seurin, S, in press. The need for paediatric formulation: oral administration of nifedipine in children, a proof of concept. J. Drug Dev. Sci. Tech.
38. S. Turner, A. Longworth, A.J. Nunn, and I. Choonara Unlicensed and off label drug use in paediatric wards: prospective study BMJ 316 1998 343 345
39. S. Turner, A.J. Nunn, K. Fielding, and I. Choonara Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study Acta Paediatr. 88 1999 965 968
40. I.C.K. Wong, M.A. Ghaleb, B.D. Franklin, and N. Barber Incidence and nature of dosing errors in paediatric medications - a systematic review Drug Saf. 27 2004 661 670
41. W. Yamreudeewong, S.N. Danthi, R.A. Hill, and J.L. Fox Stability of ondansetron hydrochloride injection in various beverages Am. J. Health Syst. Pharm. 52 1995 2011 2014
42. V. Yeung, C. Tuleu, and I. Wong Extemporaneous manipulation of drugs in a paediatric hospital pharmacy: a national audit Paediatr. Perinatal Drug Ther. 6 2004 75 80